NURI ALBERGA: Open Payments
NPI 1861020448 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$319 in 13 payments from 6 companies in 2025. Trend: 2023 $714 · 2024 $1,096 · 2025 $319
Food & beverage: $319
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $100 |
| Neurocrine BioSciences, Inc. | 3 | $98 |
| Indivior Inc. | 2 | $58 |
| E.R. Squibb & Sons, L.L.C. | 1 | $27 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
Products named: REXULTI, INGREZZA, SUBLOCADE, COBENFY, INVEGA SUSTENNA, UZEDY.
Industry payments across CA — which companies pay providers there.
